Maier, Simon
Nickel, Kathrin
Lange, Thomas
Oeltzschner, Georg
Dacko, Michael
Endres, Dominique
Runge, Kimon
Schumann, Anke
Domschke, Katharina
Rousos, Michalis
Tebartz van Elst, Ludger
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (MA 7813/1-1, TE 280/15-1)
Universitätsklinikum Freiburg
Article History
Received: 28 June 2023
Accepted: 10 November 2023
First Online: 17 November 2023
Declarations
:
: The study followed the declaration of Helsinki and was approved by the Ethics Committee of the University of Freiburg, Germany (Approval ID: 268/17). All participants gave written informed consent.
: Not applicable.
: KD: Steering Committee Neurosciences, Janssen. LTvE: Advisory boards, lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen, and Cyberonics. All other authors declare that they do not have any conflicts of interest.